Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 52 (KRT8P52) is a pseudogene; it does not code for a protein and is not recognized as a functional gene or therapeutic target. Pseudogenes like KRT8P52 are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or incomplete sequences. There is no evidence linking KRT8P52 directly to biological functions, disease processes, drug interactions, or its use as a biomarker[2][4][6]. KRT8P52 is a noncoding pseudogene, not a molecular target for therapeutics. It should not be confused with the functional gene KRT8 (Keratin 8), which is a type II keratin involved in epithelial structure, but KRT8P52 itself has no known direct function and no role in disease currently described[2][4]. The correct classification is under "Other (Pseudogene)"; functional, disease, or pharmacological attributes are not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 52 (KRT8P52).